Roche launches Elecsys Anti-p53 immunoassay to aid diagnosis of various cancer types . Anti-p53 antibodies are antibodies that mistakenly target a patient's own tissues, leading to a growth of solid tumors. .Screening for Anti-p53 helps to diagnose oesophageal, bowel and breast cancers earlier, thereby increasing the chances that a patient responds to a treatment .The Elecsys Anti-p53 could be used to monitor cancer cell remnants in the patient’s body ? .Basel, 07 April 2021...